SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription (Q39068468)

8 September 2017

title

SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription (English)

1 reference

8 September 2017

1 reference

Cheng Liu

1 reference

8 September 2017

Chang Wang

1 reference

8 September 2017

Kun Wang

1 reference

8 September 2017

Li Liu

1 reference

8 September 2017

Qi Shen

1 reference

8 September 2017

Keqiang Yan

1 reference

8 September 2017

Xiaoqing Sun

1 reference

8 September 2017

Jie Chen

1 reference

8 September 2017

Jikai Liu

1 reference

8 September 2017

Hongbo Ren

1 reference

8 September 2017

Hainan Liu

1 reference

8 September 2017

Zhonghua Xu

1 reference

8 September 2017

Sanyuan Hu

1 reference

8 September 2017

Dawei Xu

1 reference

8 September 2017

Yidong Fan

1 reference

8 September 2017

language of work or name

English

0 references

publication date

30 October 2013

1 reference

Journal of the National Cancer Institute

8 September 2017

published in

1 reference

8 September 2017

volume

105

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

1719-1728

1 reference

Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Epigenetic regulation of androgen receptor signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Enhanced SMYD3 expression is essential for the growth of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Androgen receptor and invasion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Histone H3 lysine 4 (H3K4) methylation in development and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

The epigenetic promise for prostate cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

NF-kappaB regulates androgen receptor expression and prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Role of the SMYD3 histone methyltransferase in tumorigenesis: local or global effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT304

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJT304

1 reference

8 September 2017

1 reference